Circulating microRNAs-a new horizon in molecular diagnosis of breast cancer

Genes and Cancer

Volumn 6, Issue 5-6, 2015, Pages 281-287

  Hagrass, Hoda A ^a   Sharaf, Samar ^a   Pasha, Heba F ^b   Tantawy, Enas A ^c   Mohamed, Randa H ^b   Kassem, Rasha ^c  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Biomarker; Breast cancer; Diagnosis; MicroRNAs; Real time PCR

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 155; MICRORNA 16; MICRORNA 195; MICRORNA 34A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84949567716     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2002; 55: 74-108.
2. Allam MF, AbdElaziz KM. Evaluation of the level of knowledge of Egyptian women of breast cancer and its risk factors. A cross sectional study. J Prev Med Hyg. 2012; 53(4): 195-198.
3. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ. Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Non invasive and Early Stage Disease. The Oncologist. 2010; 15:673-682.
4. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ. MicroRNAs as Novel Biomarkers for Breast Cancer. J Oncol. 2010; Article ID 950201, 7 pages. http://dx.doi.org/10.1155/2010/950201
5. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16): 7065-70.
6. Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, Guenther SM, O’Leary JJ, Sheils O. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 2007; 7:1-6.
7. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. Serum microRNAs are promising novel biomarkers. PLoS ONE. 2008; 3(9):e3148. doi: 10.1371/journal.pone.0003148.
8. VanSchooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res. 2012; 14(1): R34.
9. Wang J, Zhao H, Tang D, Wu J, Yao G, Zhang Q. Over expressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis. Cancer Biother Radiopharm. 2013; 28(4): 283–288.
10. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Hagg C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006; 5:24.
11. Ma L, Teruva-Feldstein J, Weinberg RA. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449:682–668.
12. Mar-Aguilara F, Mendoza-Ramíreza JA, Malagón- Santiagoa I, Espino-Silvad PK, Santuario-Facioc SK, Ruiz- Floresd P, Rodríguez-Padillab C, Reséndez-Péreza D. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Disease Markers. 2013; 34:163–169.
13. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T, Masutani H, Onuki J, Toyokuni S. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci. 2007; 98:1845-1852.
14. Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Research. 2010; 12:R90.
15. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, MacDougald OA, Cho KR, Fearon ER. p53- mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007; 17:1298-1307.
16. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Orntoft TF, Andersen CL, Dobbelstein M. p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008; 68:10094-10104.
17. Javeri A, Ghaffarpour M, Taha MF, Houshmand M. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Med Oncol. 2013; 30:413.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, lanza G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006; 103:2257–2261.
19. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients. Chin J Cancer Res. 2013; 25(1):46-54.
20. Wang F, Zheng Z, Guo J, Ding X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecologic Oncology. 2010; 119:586–593.
21. Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes. 2009; 2:89.
22. Zhang H, Su B, Zhou QM, Lu YY. Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells. Ai Zheng. 2009; 28:493–499.
23. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ. MicroRNA-155 is regulated by the transforming growth factor beta/ Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol. 2008; 28:6773-6784.
24. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010; 251:499–505.
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19:403–10.
26. Tavassoeĺi FA, Devilee P. Pathology and genetics: Tumours of the breast and female genital organs (WHO Classification of Tumors). IARC Press. 2003; p10.
27. Lowery AJ, Miller N, McNeill RE, Kerin MJ. MicroRNAs as prognostic indicators and therapeutic targets: Potential effect on breast cancer management. Clin Cancer Res. 2008; 14:360 –365.
28. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, Van Zandwijk N, Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011; 6 (9):e24145. Doi:10.1371/journal.pone.0024145.
29. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 2008; 9:76.